Ridwan Salaam | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

Mr. Ridwan Salaam | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

University of Ibadan | Nigeria

Author Profile

Orcid

Google Scholar

🌟 Early Academic Pursuits

Ridwan Salaam’s academic journey reflects a deep commitment to scientific excellence. His Bachelor’s degree from Obafemi Awolowo University (OAU) laid the foundation for his expertise in molecular genetics, with a thesis focused on the chromosomal studies of Arvicanthis niloticus. He graduated with a Second Class Upper degree, achieving a remarkable GPA of 4.19/5.0. Building on this, he pursued a Master’s degree at the University of Ibadan, earning a distinction (GPA: 6.2/7.0). His thesis investigated the antiplasmodial activity of phytocompounds using in silico pharmacology, supervised by esteemed scholars like Dr. Afolayan Funmilayo I.D.

🚀 Professional Endeavors

With hands-on research experience spanning academia and industry, Ridwan has excelled in roles such as Research Intern at Hackbio, Graduate Research Assistant at the University of Ibadan, and Research Assistant at OAU. He has mastered advanced bioinformatics tools, molecular docking, and statistical analysis, actively contributing to cancer and infectious disease studies. His contributions extend to mentoring students, conducting DNA extractions, and organizing independent research groups like the Computer-Aided Biological Research Group (COMBReG).

🧬 Contributions and Research Focus

Ridwan’s research spans Cell Biology, Molecular Genetics, Drug Discovery, and Immunotherapy, with an emphasis on cancer and infectious diseases. He has published extensively on computational drug discovery, molecular docking, and network pharmacology. Notable works include elucidating antiplasmodial mechanisms and exploring phytocompounds for cancer treatments. He has participated in groundbreaking projects, such as developing multipotent antivenom under the 2023 TETFUND National Research Fund.

🏆 Accolades and Recognition

Ridwan’s achievements have garnered national and international recognition. His certificate of commendation from Government Secondary School, Maina, acknowledges his teaching contributions, while multiple workshop certifications highlight his expertise in computer-aided drug design and vaccine development. His collaborative research efforts have been showcased at prestigious conferences like the Zoological Society of Nigeria Annual Conference and the International Conference on Scientific Research in Nigeria.

🌍 Impact and Influence

As a convener of COMBReG and a research team coordinator, Ridwan has demonstrated exceptional leadership by fostering collaborative environments and driving innovation. He has trained over 40 participants in bioinformatics and spearheaded projects addressing global health challenges like malaria and cancer. His ability to work across diverse cultural and professional backgrounds has solidified his reputation as a team player and mentor.

📜 Legacy and Future Contributions

Ridwan Salaam’s robust academic background and research endeavors position him as a trailblazer in molecular genetics and bioinformatics. His work not only addresses pressing global health issues but also inspires future generations of scientists. With ongoing research in computational drug discovery and molecular pathways, Ridwan’s contributions are poised to leave a lasting impact on the fields of cancer therapy and infectious disease treatment. His journey exemplifies the spirit of innovation and dedication, promising a legacy of transformative research.

 

Publications


📄 A Review of Selected Parasitic Plants in Nigeria: Converting Harms to Benefits

Authors: Funmilayo I. D. Afolayan, Ridwan A. Salaam, Ebenezer S. Oladokun, Samson D. Adesoye
Journal: Natural Therapy Advances
Year: 2024


📄 Antiplasmodial Mechanism of Lawsonia inermis: An In Silico-Based Investigation

Authors: Ridwan Abiodun Salaam, Funmilayo I. D. Afolayan
Journal: Infectious Diseases Research
Year: 2024


📄 In Silico Discovery of Potential Androgen Receptor and Cytochrome P450 17A1 Inhibitors from Camellia sinensis for Prostate Cancer Treatment

Authors: Ridwan Abiodun Salaam, Christopher Terseer Tarkaa, Rachael Pius Ebuh, Damilare Adebayo Olaniyi, Sayo Ebenezer Oladokun, Rodiat Omotola Sowemimo, Oluwaponmile Florence Ajayi, Olusola Abayomi Akangbe
Journal: Next Research
Year: 2024


📄 In Silico and In Vivo Evaluations of Multistage Antiplasmodial Potency and Toxicity Profiling of n-Hexadecanoic Acid Derived from Vernonia amygdalina

Authors: Funmilayo I. D. Afolayan, R. A. Odeyemi, Ridwan A. Salaam
Journal: Frontiers in Pharmacology
Year: 2024


📄 Elucidating the Molecular Targets of Curcuma longa for Breast Cancer Treatment Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation

Authors: Christopher Terseer Tarkaa, Damilare Adebayo Oyaniyi, Ridwan Abiodun Salaam, Rachael Pius Ebuh, Olusola Abayomi Akangbe, Sayo Ebenezer Oladokun, Rodiat Omotola Sowemimo, Oluwaponmile Florence Ajayi
Journal: Precision Medicine Research
Year: 2023


 

Hai Tang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Hai Tang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Sun Yat-sen University | China

Author Profile

Orcid

Early Academic Pursuits

Dr. Hai Tang commenced his academic journey with a Bachelor's degree in Pharmacy and molecular biology, followed by a Master's degree in bioinformatics and molecular biology. These foundational studies laid the groundwork for his subsequent endeavors in academia and research.

Professional Endeavors

After completing his master's degree, Dr. Tang embarked on teaching and research roles at Guangdong Jiangmen Chinese Medicine College and the Southern Medical University Affiliated Maternal and Child Health Hospital of Foshan. Here, he delved into bioinformatics and molecular biology, honing his expertise and contributing to academic and scientific communities.

Contributions and Research Focus

Dr. Tang's primary research revolves around machine learning, bioinformatics, and molecular biology, particularly in the realms of preeclampsia, Alzheimer's disease, and cancers. He focuses on identifying novel biomarkers to enhance early diagnosis and treatment strategies for these diseases. His contributions include participation in various research projects funded by prestigious institutions and the publication of several SCI papers.

Accolades and Recognition

Dr. Tang's notable achievements include publications in esteemed journals like Computers in Biology and Medicine. He has been involved in impactful research initiatives, demonstrating his ability to translate conceptual ideas into tangible outcomes.

Impact and Influence

Through his dedication to advancing machine learning, bioinformatics, and molecular biology, Dr. Tang has made significant contributions to his field. His research outcomes have the potential to influence clinical practice and contribute to advancements in medical diagnostics and treatments.

Legacy and Future Contributions

Dr. Tang's commitment to staying abreast of the latest advancements and his active engagement in academic and industry communities position him as a driving force in future research endeavors. His legacy lies in his contributions to cutting-edge research and the practical application of his findings in real-world medical and biological contexts

Notable Publications

Lysosome-related biomarkers in preeclampsia and cancer: Machine learning and bioinformatics analysis 2024

Role of breastfeeding on maternal and childhood cancers: An umbrella review of meta-analyses 2023 (2)

Lycopene protects neuroblastoma cells against oxidative damage via depression of ER stress 2020 (9)

Lycopene alleviates oxidative stress via the PI3K/Akt/Nrf2pathway in a cell model of Alzheimer’s disease 2020 (23)

Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP/PS1 transgenic mce 2019 (19)